ACRV
Acrivon Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.62
+0.01 ▲ +0.62%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$1.60
-0.02 ▼ -1.23%
| Index | - | P/E | - | EPS (ttm) | -2.13 | Insider Own | 29.63% | Shs Outstand | 0.03B | Perf Week | 4.52% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | 4.46% | Insider Trans | 0.73% | Shs Float | 0.02B | Perf Month | 8% |
| Enterprise Value | -0.08B | PEG | - | EPS next Q | -0.48 | Inst Own | 51.81% | Short Float | 9.61% | Perf Quarter | -38.17% |
| Income | -0.08B | P/S | - | EPS this Y | 14.91% | Inst Trans | 4.33% | Short Ratio | 1.24 | Perf Half Y | 4.52% |
| Sales | 0.00B | P/B | 0.4 | EPS next 5Y | 7.18% | ROA | -45.42% | Short Interest | 2.14M | Perf YTD | -32.78% |
| Book/sh | 4.08 | P/C | 0.4 | EPS past 3/5Y | -45.2% -74.96% | ROE | -50.23% | 52W High | -71.33% ($5.65) | Perf Year | -68.05% |
| Cash/sh | 4.1 | P/FCF | - | Sales past 3/5Y | - | ROIC | -62.69% | 52W Low | 54.29% ($1.05) | Perf 3Y | -92.31% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 21.17% | Gross Margin | - | Volatility(W/M) | 6.12% 7.56% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.13 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.75 | EPS Q/Q | 19.7% | Profit Margin | - | RSI (14) | 47.41 | Recom | 1.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.75 | Sales Q/Q | - | SMA20 | 0.87% ($1.61) | Beta | 1.66 | Target Price | $11.5 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 11000000 | SMA50 | -10.33% ($1.81) | Rel Volume | 0.42 | Prev Close | $1.61 |
| Employees | 78 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 20.49% - | SMA200 | -6.07% ($1.72) | Avg Volume(3M) | 1.72M | Price | $1.62 |
| IPO | 2022/11/15 | Option/Short | No/Yes | Trades | 1870 | Volume | 728,086 | Change | 0.62% |
뉴스 로딩 중...